Subject(s)
Humans , Male , Female , Middle Aged , Pyelonephritis/diagnosis , Pyelonephritis/therapy , Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Drug Resistance , Risk Factors , Escherichia coli/pathogenicity , Pyelonephritis/physiopathology , Bacteriuria/complications , Bacteriuria/diagnosis , Sensitivity and SpecificityABSTRACT
Women with diabetes mellitus suffer symptomatic bacteriuria and symptomatic urinary infections more often than non-diabetic women. Prevalence is similar, however, in males with and without diabetes. There is a controversy on the impact of asymptomatic bacteriuria on the development of complications in diabetic patients. Current evidence is reviewed concerning the need for detection and treatment of asymptomatic bacteriuria in these patients.
Subject(s)
Bacteriuria/complications , Diabetes Complications , Diabetes Mellitus/urine , Bacteriuria/diagnosis , Bacteriuria/therapy , Diabetes Complications/microbiology , Female , Humans , MaleABSTRACT
Las mujeres con diabetes mellitus tienen bacteriuria sintomática e infecciones urinarias sintomáticas más frecuentemente que las mujeres no diabéticas. La prevalencia es similar en varones con y sin diabetes. Existe controversia sobre las repercusiones que la presencia de bacteriuria asintomática tiene sobre el desarrollo de complicaciones en pacientes diabéticos. Se revisan las evidencias actuales acerca de la necesidad del despistaje y tratamiento de la bacteriuria asintomática en estos pacientes
Women with diabetes mellitus suffer symptomatic bacteriuria and symptomatic urinary infections more often than non-diabetic women. Prevalence is similar, however, in males with and without diabetes. There is a controversy on the impact of asymptomatic bacteriuria on the development of complications in diabetic patients. Current evidence is reviewed concerning the need for detection and treatment of asymptomatic bacteriuria in these patients
Subject(s)
Male , Female , Humans , Bacteriuria/complications , Diabetes Mellitus/complications , Diabetes Mellitus/urine , Bacteriuria/diagnosis , Bacteriuria/therapyABSTRACT
We describe the remarkable case of a patient with septicemia caused by Non 0-1 Vibrio Cholerae associated with skin lesion of the lower and upper extremities. This patient suffered from chronic liver disease and a cervix carcinoma in IIIB stage, she had been admitted to the hospital the day before for dicompensated ascites. She received intravenous cefotaxime and had a satisfactory recovery and was completely free of signs and symptoms. We report its epidemiological discovery in inland freshwater and this is the first announced case in Spain with this confirmed environmental isolation and a rare report case in the literature.
Subject(s)
Bacteremia/microbiology , Cholera/microbiology , Immunocompromised Host , Vibrio cholerae/isolation & purification , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Cefotaxime/therapeutic use , Cholera/drug therapy , Female , Humans , Neoplasm Staging , Treatment Outcome , Uterine Cervical Neoplasms/pathologyABSTRACT
Describimos el caso poco frecuente de una paciente con una sepsis por Vibrio Cholerae no 0-1 asociado a lesiones cutáneas en extremidades inferiores y superiores. Esta paciente padecía de una hepatopatía crónica y un carcinoma de cérvix en estadío IIIB y había sido ingresada el día previo por una descompensación ascítica. Su evolución fue buena con resolución completa mediante cefotaxima endovenosa. Destacar sobre todo el hallazgo de su origen epidemiológico, aguas continentales de pozos naturales, siendo esta particularidad la que hace de este caso el primero descrito en España con ese origen demostrado y un caso excepcional en la literatura mundial revisada (AU)
Subject(s)
Aged , Female , Humans , Immunocompromised Host , Vibrio cholerae , Bacteremia , Treatment Outcome , Anti-Bacterial Agents , Cholera , Cefotaxime , Neoplasm Staging , Uterine Cervical NeoplasmsSubject(s)
Hepatitis/microbiology , Syphilis, Latent/diagnosis , Aged , Humans , Male , Time FactorsABSTRACT
No disponible
Subject(s)
Aged , Male , Humans , Syphilis, Latent , Time Factors , HepatitisABSTRACT
No disponible
Subject(s)
Aged , Female , Humans , Postoperative Complications , Drug Resistance, Microbial , Urinary Tract Infections , Urinalysis , Nail Diseases , Outpatients , Reflex Sympathetic Dystrophy , Microbial Sensitivity TestsABSTRACT
Inflammatory Bowel Disease (IBD), as Ulcerative Colitis (UC) as well as Crohn's Disease (CD), can appear as severe outbreak resistant to steroid treatment. These cases require surgery or immunosupressive therapy (mercaptopurine or azathioprine). Cyclosporine A (CYA) is a selective, reversible immunosupressor of the T helper lymphocites, used in the treatment of organ transplants and in certain autoimmune diseases. CYA is not a first line therapy for IBD. In spite of the positive results obtained in some uncontrolled studies, only one randomized trial has shown the superiority of CYA over the placebo in the treatment of UC and avoided colectomy in one third of the patients with the severe form of this disease. It can also contribute to the healing of resistault CD fistulaes. The potential toxicity of CYA and the few controlled clinical trials limit its use. However CYA needs to define its role in the treatment of IBD through II more controlled trials.
Subject(s)
Cyclosporine/therapeutic use , Immunosuppressive Agents/therapeutic use , Inflammatory Bowel Diseases/drug therapy , HumansABSTRACT
A patient with advanced multiple myeloma (MM) and renal failure presented a severe chronic anemia requiring frequent blood transfusions. Treatment with recombinant human erythropoietin (rHuEPO) led to a rapid improvement of anemia, and further blood transfusions were not required. Pathophysiological studies about the erythropoiesis in patients with MM and trials with rHuEPO in myeloma-associated anemia are commented.
